Biosurfit
1 known investors
Biosurfit develops point-of-care diagnostic technology that produces lab-quality results from a single finger-prick blood sample. Its disposable disc platform can combine immunoassays, haematology, and clinical chemistry analytes in one test to support physicians' diagnostic and treatment decisions.
Investors · 1
Frequently asked questions
- What does Biosurfit do?
- Biosurfit develops point-of-care diagnostic technology that produces lab-quality results from a single finger-prick blood sample. Its disposable disc platform can combine immunoassays, haematology, and clinical chemistry analytes in one test to support physicians' diagnostic and treatment decisions.
- Who are Biosurfit's investors?
- Biosurfit's investors include Beta Capital.